Copycat drugs can save consumers money in the short term. But the societal cost of the signals this sends to the ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.

The Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs used for weight loss and diabetes management.

If the secretary of Health and Human Services truly wants to solve America’s obesity crisis, he must understand that lifestyle changes aren’t always enough.

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Megan Stalter, who portrays Kayla in the Max drama "Hacks," slammed those who lie about taking Ozempic for weight-loss ...

Hims & Hers Health ( HIMS 3.08%) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach ...